Eli Lilly hands transpacific biotech upstart Terns pieces to an experimental NASH puzzle
For Weidong Zhong, the fastest part of starting up a transpacific biotech was finding the money.
Almost immediately after stepping out of Novartis’ early-stage research …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.